For the first episode of 2024, Senior Reporter Katie Adams discussed some executive hires, promotions and departures that recently took place in the healthcare world, as well as layoffs affecting ...

Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has ...

Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.

This month, Moon Surgical received FDA clearance for the commercial version of its Maestro surgical robot system. The system is designed to support surgeons and other operating room staff ...

Checkpoint inhibitors transformed cancer treatment, bringing to patients immunotherapies now widely used to treat a range of tumors. But there are different types of checkpoints that interact with ...

ƒ dÝT £Hõ®½Æ,‹çÞòéBo ­Ó` š˜…‡ ¯ Ãj(âXX äV’ù’ÛŽ ¯W• ¨¼ü_ Îeñ /™„ 7/ZaYG5 P ºYfI= ž ü`¬úx¸¬™N~W Õs€½£Ë v ¨]u|d5Œ ÅsÛtÉ WSŠ‰ŠU ...

The business is poised to compete with Bright Health, which offers plans for individuals and Medicare recipients, and Clover Health, a health insurance startup that focuses on Medicare members.

Several telehealth advocates are coming out in support of the Drug Enforcement Administration’s (DEA) third extension of Covid-19 telehealth flexibilities for the prescribing of controlled ...

Medicine stands at a remarkable crossroads. The explosive growth in specialty drug development marks a new golden age of therapeutic innovation. In 1990 there were just 10 specialty drugs on the ...

Keytruda, a Merck cancer immunotherapy that has become the world’s top-selling medication, is administered as an intravenous infusion over the course of 30 minutes. The pharmaceutical giant now ...

In a typical year, at least 1.7 million adults in America develop sepsis, a life-threatening response to infection. About 30% of severe sepsis patients don’t survive, and up to 50% of survivors ...